SOX2 and glioblastoma: Consistent with these findings from experimental cell models in vitro, ChIP-PCR analysis shows Sox2, Oct4, and HMGA1 binding to the TGBFR2 promoter in cells isolated from recurrent GBM patient-derived xenografts (PDX) (Fig. 2j).